Sulfacetamide → HCID 178475155, 화합물
반응식
C(O[CH:4]=[C:5]1[C:16]2[C:8](=[CH:9][CH:10]=[C:11]3[C:15]=2[S:14][CH:13]=[N:12]3)[NH:7][C:6]1=[O:17])C.[C:18]([NH:21][S:22]([C:25]1[CH:30]=[CH:29][C:28]([NH2:31])=[CH:27][CH:26]=1)(=[O:24])=[O:23])(=[O:20])[CH3:19]>>[C:18]([NH:21][S:22]([C:25]1[CH:30]=[CH:29][C:28]([NH:31][CH:4]=[C:5]2[C:16]3[C:8](=[CH:9][CH:10]=[C:11]4[C:15]=3[S:14][CH:13]=[N:12]4)[NH:7][C:6]2=[O:17])=[CH:27][CH:26]=1)(=[O:24])=[O:23])(=[O:20])[CH3:19]참가 물질
3
실험 절차
The title compound was prepared in 26% yield from 8-ethoxymethylene-6,8-dihydro-1-thia-3,6-diaza-as-indacen-7-one and N-acetyl-4-aminobenzenesulfonamide according to Procedure J: 1H NMR (DMSO-d6): δ12.0 (s, 1H), 11.2 (d, 1H), 10.9 (s, 1H), 8.1 (d, 1H), 7.9 (m, 3H), 7.6 (d, 2H), 7.1 (d, 1H), 2.0 (s, 3H); ESI−MS m/z413 (M−H)−.
출처 및 근거
- ORD 기록
- ord-c6e9c057838f45d080e8f856c66b1673
- 출처 데이터셋
- uspto-grants-2002_04
- 특허 번호